Congenital heart disease (CHD) is a condition that affects around 0.8% of newborn infants worldwide. Due to recent medical and surgical improvements, more than 85% of these infants now survive into adulthood [1, 2]. Most treatments have not successfully cured the problem, and around 50% of adults with congenital heart disease will need additional surgery and are at risk of arrhythmia, heart failure, and premature death if not appropriately controlled. Women with innate heart conditions encounter extra obstacles when pregnant.